The 100 Most Influential People in Oncology in 2025 https://t.co/4I3CRGAiZE The 100 Most Influential People in Oncology in 2025 recognizes the changemakers in cancer care who have helped shape current practice in oncology and continue to drive innovation and research towards

Key Takeaways From AGO-OVAR 2.29/ENGOT-ov34 and What Comes Next for Immunotherapy - Kristina Lindemann @JCO_ASCO https://t.co/CIdnZofnh9 #OncoDaily #Oncology #Cancer #Health #Medicine #Immunotherapy

A Strategy to Support the Aging Immune System by Turning the Liver Into a Temporary Factory for Immune Signals - @mircoscopy https://t.co/3HFrpxSJCD #Cancer #Medicine #Health #Oncology #OncoDaily #CancerResearch #MedX #MedNews #MedEd

Building the Data-First Future of Immunotherapy - @ay_zhou @CancerResearch https://t.co/1EJDy9e0hq #Cancer #Medicine #Health #Oncology #OncoDaily #Immunotherapy #MedX #MedNews #MedEd

Analyzing the Rapidly Expanding Landscape of Bispecific Antibodies in Solid Tumors - @Jani_Chinmay https://t.co/1KKlsLsEeV #Cancer #Medicine #Health #Oncology #OncoDaily #CancerResearch #SolidTumors #BispecificAntibodies #MedX #MedNews #MedEd

What If the Better Answer to Solid Tumor CAR T Cells Lies Outside the Tumor Itself? - Amanda Finck https://t.co/boAc4NFavd #Cancer #Medicine #Health #Oncology #OncoDaily #CancerResearch #MedX #MedNews #MedEd

One-Product-Fits-All Immunotherapy for Pancreatic Cancer - Hung Trinh @UCLA https://t.co/qicMRIPKwm #Cancer #Medicine #Health #Oncology #OncoDaily #Immunotherapy #PancreaticCancer #MedX #MedNews #MedEd

Cancer Research Institute - MiTEs Dual Target Immunotherapy for Solid Tumors @CancerResearch https://t.co/19W9gjVHBg #Cancer #Medicine #Health #Oncology #OncoDaily #Immunotherapy #MedX #MedNews #MedEd

Proud of Lamberto Torralba-Raga and the ECHO Precision Immunotherapy Project - Karl-Johan Malmberg @LambertoTR https://t.co/IvrdKLQ9vP #OncoDaily #Oncology #Cancer #Health #Medicine #ECHO #Immunotherapy

Immunotherapy saves lives but only if drug integrity is protected. 🧊Temp-sensitive biologics 📦Cold chain risks 👩‍⚕️Pharmacists as safety gatekeepers From storage to bedside, safety matters. Read more: https://t.co/aUz3Zbm8ls @thermofisher @dhlsupplychain #Immunotherapy

Winship Cancer Institute (@WinshipAtEmory) Hosts 2025 Cancer Immunology Research Program Retreat - @Chrystal_Paulos https://t.co/RvuHd6j74S #Cancer #ImmunOnc #Immunology #OncoDaily #Oncology #MedEd #MedTwitter #MedX #MedOnc @CancerWorldmag

A Paradigm Shift in How We Think About Tregs in Cancer - @YLeyfman https://t.co/PWWgQD9qzP #Cancer #IO #ImmunOnc #Immunotherapy #ColorectalCancer #OncoDaily #Oncology #MedEd #MedTwitter #MedX #MedOnc @CancerWorldmag

The Dawn of Synthetic Spatial Biology - Carlo Bifulco @BernardAFox https://t.co/VcWyv6J4oz #Cancer #Medicine #Health #Oncology #OncoDaily #CancerResearch #Biology #MedX #MedNews #MedEd

Adjuvant PD-1 vs BRAF/MEK in Stage III Melanoma - @DoniaMarco https://t.co/HVfZ8WFBdB #Cancer #Medicine #Health #Oncology #OncoDaily #Melanoma #CancerTreatment #MedEd #MedX #MedNews

Presenting Atezolizumab–Bevacizumab Outcomes in HCC at @myESMO Immuno-Oncology 2025 - @RichyP56 https://t.co/EXZqsF1BOa #Cancer #Medicine #Health #Oncology #OncoDaily #ESMOImmuno25 #MedX #MedNews #MedEd #HCC

Are ADCs Immunotherapies? - @LauBuisseret https://t.co/L4Zqv90RXA #ESMOImmuno25 #Cancer #Medicine #Health #Oncology #OncoDaily #MedX #MedNews #MedEd

Proud to Contribute to Collaborative Immuno-Oncology Efforts at @myESMO Immuno25 - Laurence Buisseret https://t.co/H2R4HInrs8 #Cancer #Medicine #Health #Oncology #OncoDaily #ESMOImmuno25 #MedX #Mednews #MedEd #ImmunoOncology

The Science of Tumor-Infiltrating Lymphocytes - @DoniaMarco @CoukosGeorge https://t.co/aao5isS4LX #Cancer #Medicine #Health #Oncology #OncoDaily #CancerResearch #MedX #MedNews #MedEd

Cell-Free DNA Methylation Profiling Reveals Immune-Related Organ Damage in Patients Receiving ICIs - @VivekSubbiah https://t.co/FO2eKqByWM #Cancer #Medicine #Health #Oncology #OncoDaily #CancerResearch #MedX #MedNews #MedEd

Agenus - How CTLA-4 Has Re-Emerged as a Central Driver of the Next Immuno-Oncology Revolution @Agenus_Bio @ODayMD https://t.co/BIETETqeuW #ImmunoOncology #ESMOIO25 #CTLA4 #CancerResearch #Biotech #Cancer #Medicine #Health #Oncology #OncoDaily #MedX #MedNews #MedEd